Incomplete lowposs nefraytis in this world.pptx

presentation about lowposs nefratyttis jst for fun and i really need the exhanged document for this

1. WILFREDO T. MATA JR., MD First Year Medical Resident APRIL 30, 2024 CRITICAL JOURNAL APPRAISAL NEGROS ORIENTAL PROVINCIAL HOSPITAL Department of Internal Medicine

2. PRESENTOR DR. WILFREDO T. MATA JR. 1 ST YEAR RESIDENT NEGROS ORIENTAL PROVINCIAL HOSPITAL Department of Internal Medicine MODERATOR DR. KRISTINE GAYLE S. PASTORPILE GENERAL INTERNIST

3. NEGROS OIENTAL PROVINCIAL HOSPITAL Department of Internal Medicine directness

4. NEGROS OIENTAL PROVINCIAL HOSPITAL Department of Internal Medicine  The patient was well represented by the population group thus he could have benefited from a single dose of ceftriaxone against early-onset VAP. In other words, the patient could have more than 50% less chance of developing VAP if he was given Ceftriaxone as prophylaxis. individualizing the results

5. NEGROS OIENTAL PROVINCIAL HOSPITAL Department of Internal Medicine AUTHOR’s conclusion

6. NEGROS OIENTAL PROVINCIAL HOSPITAL Department of Internal Medicine Day 60 outcomes: Ceftriaxone group had lower ICU stay, shorter hospital stay, and lower mortality rates . Bacterial findings: Polymicrobial VAP cases, most common bacteria include Staphylococcus aureus, Streptococcus spp , Haemophilus spp , and Escherichia coli . Low rate of resistant bacteria isolated, few cases of Clostridium difficile infection and ESBL-producing Enterobacteriaceae. Author’s conclusion

7. NEGROS OIENTAL PROVINCIAL HOSPITAL Department of Internal Medicine Adverse events: Majority are related to initial disease, and one possible hypersensitivity reaction in placebo group . Conclusion: Ceftriaxone is effective in preventing VAP in acute severe brain injury patients, with favorable outcomes and no safety concerns. Author’s conclusion

8. ADMITTING IMPRESSION Acute Cerebrovascular Disease, probably infarct; NIHSS 25 Differentials Acute Cerebrovascular Disease, probably infarct; NIHSS 25

9. Fully Editable Shapes

10. Fully Editable Shapes

11. Fully Editable Icon Sets: A

12. Fully Editable Icon Sets: B

13. Fully Editable Icon Sets: C